Home > Journals > Minerva Endocrinology > Past Issues > Articles online first > Minerva Endocrinology 2021 Apr 01

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

Minerva Endocrinology 2021 Apr 01

DOI: 10.23736/S2724-6507.21.03349-6

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Polycystic ovary syndrome and obesity: clinical aspects and nutritional management

Evelyn FRIAS-TORAL 1, 2 , Eloisa GARCIA-VELASQUEZ 3, Maria de los ANGELES CARIGNANO 4, Dolores RODRIGUEZ-VEINTIMILLA 5, Irene ALVARADO-AGUILERA 6, Noemi BAUTISTA-LITARDO 7

1 Research Committee, SOLCA Guayaquil, Av. Pedro Menendez Gilbert, Guayaquil, Ecuador; 2 Palliative Care Residency from Universidad Católica Santiago de Guayaquil, Guayaquil, Ecuador; 3 Clinical Nutrition Service, San Francisco Clinic Hospital, Guayaquil, Ecuador; 4 Nutritional Support Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; 5 Clinical Nutrition and Dietetics Service, SOLCA Guayaquil, Ecuador; 6 Espiritu Santo, Universidad, Guayaquil, Ecuador; 7 Endocrinology Service, SOLCA Guayaquil, Ecuador


PDF


INTRODUCTION: Polycystic Ovary Syndrome (PCOS) is a multifactorial endocrine and metabolic disorder characterized by androgen excess, oligo-anovulatory infertility, polycystic ovaries in ultrasound examination, insulin resistance, and cardiometabolic disorders, with overweight/obesity and visceral adiposity. This review aims to provide an overview of the clinical characteristics and nutritional therapy of PCOS and obesity.
METHODS: The authors analyzed the updated and relevant publications found on Pubmed about clinical aspects and nutritional management of PCOS and obesity in studies done in animal and human models.
DISCUSSION: It is crucial an early detection and intervention in PCOS patients to avoid the more challenging control of the onset of more impaired-health conditions that this pathology causes. It is presented evidence that clearly shows the close interaction among oxidative stress, low-grade inflammation, and PCOS. It is also analyzed the relevance of treating metabolic and nutritional correlations of PCOS with a complete therapeutic strategy that includes individualized medication, diet, and healthy habits.
CONCLUSIONS: By an integral approach and treatment that includes not only medications for PCOS symptoms, supplementation of minerals and vitamins to control PCOS complications but an antiinflammatory diet, nutritional education, exercise individualized program, lifestyle changes, it is possible to improve insulin resistance, sustained weight loss, ovulation rates, among other goals for the management of this disease. Further studies are needed to clarify mechanisms, beneficial effects, and doses of supplements and precise medication to determine the best combination of diets and exercise programs according to these patients' specific requirements.


KEY WORDS: Polycystic ovary syndrome; Oxidative stress; Low-grade chronic inflammation; Obesity; Hyperandrogenism; Insulin resistance; Lifestyle; Diet modification

top of page